• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

1.240 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revelation Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
February 26, 2026
Via ACCESS Newswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
January 26, 2026
Via Chartmill
News headline image
REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year ↗
January 26, 2026
Revelation Biosciences said its 1-for-4 reverse stock split will become effective from January 28, 2026. 
Via Stocktwits
News headline image
American Lithium Minerals (OTC: AMLM) Accelerates Global Expansion Across Gold, Silver, Copper, Critical Minerals, and Rare Earth Elements
January 26, 2026
Via AB Newswire
Revelation Biosciences Stock Slides 17% After Company Reports 3 Severe Adverse Events In Early Stage Trial Of Inflammation Drug ↗
September 09, 2025
Via Stocktwits
What's going on in today's session ↗
January 23, 2026
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
January 23, 2026
Via Chartmill
Which stocks are moving on Friday? ↗
January 23, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Friday. ↗
January 23, 2026
Via Chartmill
Thursday's session: top gainers and losers ↗
January 22, 2026
Via Chartmill
News headline image
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
January 21, 2026
Via ACCESS Newswire
News headline image
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
January 14, 2026
Via ACCESS Newswire
News headline image
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 12, 2026
Via ACCESS Newswire
News headline image
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development
January 07, 2026
Via ACCESS Newswire
News headline image
Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting
December 01, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
November 20, 2025
 
Via Benzinga
News headline image
Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year
November 20, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
November 10, 2025
 
Via Benzinga
News headline image
REVELATION BIOSCIENCES INC (NASDAQ:REVB) Reports Q3 2025 Loss, Announces Groundbreaking Clinical Data and Improved Cash Runway ↗
November 06, 2025
Revelation Biosciences posts wider Q3 loss but secures funding, extends cash runway into 2026 following positive Gemini study data. 
Via Chartmill
News headline image
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025
November 06, 2025
Via ACCESS Newswire
News headline image
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date
October 29, 2025
Via ACCESS Newswire
News headline image
Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025
October 15, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
September 11, 2025
 
Via Benzinga
News headline image
Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds
September 11, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
September 10, 2025
 
Via Benzinga
News headline image
Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data
September 10, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
September 09, 2025
 
Via Benzinga
News headline image
Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data
September 09, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
September 09, 2025
 
Via Benzinga
News headline image
Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study
September 09, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap